We use cookies to improve your experience and for marketing. Read our cookie policy or manage cookies.

Accept essential cookies
Accept all cookies
World - Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
Report Update: Jun 1, 2025

World - Antibiotics - Market Analysis, Forecast, Size, Trends And Insights

Single report
Sent by email within 24h (Mon-Fri)
What's the difference?
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing
August 6, 2015 at 9:00 PM GMT+0

China’s Exports of Antibiotics Keep Rising, So Do Antibiotic Resistance Issues

China is one of the largest global producers and consumers of antibiotics. In 2014, China exported X% of its total antibiotics output. Of this amount, X% was supplied to India, where Chinese antibiotics held a X% share of total India's consumption.

In 2013, China and Italy were the main global suppliers of antibiotics with a combined share of X% of global exports, remaining the fastest growing exporters. From 2007 to 2014, average annual growth rates of antibiotics exports from these countries stood at X% and X%, respectively. Despite being the largest global producers of antibiotics, Thailand and the Republic of Korea did not export much of their production, meaning that it was either domestically consumed.

In 2014, Italy (X%), India (X%), France (X%), Germany (X%) and the U.S. (X%) were the leading destinations of antibiotics imports, together making up X% of global imports in value terms. And while the share of France increased significantly, the share of Italy illustrated negative dynamics. The shares of the other countries remained relatively stable throughout the analyzed period.

Antibiotics were invented at the beginning of the X century and were almost immediately recognized as a crucial discovery that revolutionized treatment of both human and animal illnesses across the globe. After WWII, the widespread use of antibiotics considerably extended a person's life span, eliminating severe diseases, such as tuberculosis, plague and leprosy.

Since X, antibiotics have been used globally in livestock production to boost weight gain, balance intestinal flora, and speed up production. However, the expansive antibiotics usage has a significant downside, particularly when abused; unfolded antibiotic resistance (AR) represents a dire menace to public health on local, national and global levels.

The possibility for successful treatment of infections is dramatically mitigated by resistant bacteria. Moreover, AR may entail dramatic complications. In the EU, infectious diseases account for less than X% of total deaths. Yet, AR bacteria cause over X thousand mortalities every year.

Likewise, in livestock, ordinary bacteria triggering diarrhea or respiratory infections became less susceptible to common veterinary antimicrobials. Due to strict regulations and the necessity of certificates and research, launching new antibiotics on the market can takes up to X years. As a result, this AR phenomenon begot losses exceeding X billion EUR.

The European Commission implemented a X strategy dedicated to combat AR in 2011. This plan includes improved monitoring, raising awareness, promoting responsible usage of antibiotics and establishing more targeted distribution in lieu of the present mass strategy.

Approximately X% of the antibiotics produced domestically in China are used in livestock production. It was estimated that X million kg of antibiotics were used in China's pork and poultry production in 2012. Antibiotic resistance (AR) already appears to be higher in China than in Western countries, and there has been a disquieting rise in the prevalence of resistant bacteria.

In the U.S., public health advocates have also come down on the long-established habit of resorting to antibiotics in producing livestock and poultry, because of antibiotic-resistant bacteria growth. Farmers defend this practice though, claiming that antibiotics are needed to keep cattle, pigs and poultry in a good state of health, and to boost meat production.

In 2012, the strategy of Food and Drug Administration (FDA) was made public. This plan serves to exterminate unsupervised use of drugs as feed additives and confine antibiotics to therapeutic use only, requiring veterinarian supervision and a prescription.

Regarding the U.S. people, antibiotics are often unnecessarily prescribed at hospitals. The Center for Disease Control and Prevention estimated that four out of five U.S. citizens are prescribed antibiotics annually. Almost X% of the estimated X million prescriptions turn out to be absolutely unneeded. A recent survey by Harvard researchers revealed that doctors prescribed antibiotics to X% of patients with sore throat, though the drug is thought to be indispensable in only X% of cases.

Source: IndexBox Market Intelligence Platform

This report provides an in-depth analysis of the global antibiotic market. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21105400 - Antibiotics

Country coverage:

Worldwide - the report contains statistical data for 200 countries and includes detailed profiles of the 50 largest consuming countries:

+ the largest producing countries

Data coverage:

  • Global market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Global production, split by region and country
  • Global trade (exports and imports)
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Company coverage:

Pfizer, Johnson & Johnson, Merck, Cubist Pharmaceuticals, Abbott Laboratories, Eli Lilly & Co, Melinta Therapeutics, Novartis, GlaxoSmithKline, Bayer, Allergan, Roche, Sanofi, STADA Arzneimittel, Shionogi & Co., Taisho Pharmaceutical Holdings, Daiichi Sankyo, Meiji Holdings Company, Astellas Pharma, Sun Pharmaceutical Industries, Cipla, Lupin, Shanghai Pharmaceuticals Holding, Dr. Reddy's Laboratories, TaiGen Biotechnology

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND THE AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS

  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional EditionPRO

  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and its Prospects

    1. MARKET SIZE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
    2. CONSUMPTION BY COUNTRY: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
    3. MARKET FORECAST TO 2035

  4. 4. MOST PROMISING PRODUCTS FOR DIVERSIFICATION

    Finding New Products to Diversify Your Business

    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCTS
    4. MOST TRADED PRODUCTS
    5. MOST PROFITABLE PRODUCTS FOR EXPORT

  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES

  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Export

    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS

  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
    2. PRODUCTION BY COUNTRY: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)

  8. 8. IMPORTS

    The Largest Import Supplying Countries

    1. IMPORTS: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
    2. IMPORTS BY COUNTRY: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
    3. IMPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)

  9. 9. EXPORTS

    The Largest Destinations for Exports

    1. EXPORTS: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
    2. EXPORTS BY COUNTRY: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
    3. EXPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)

  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

  11. 11. COUNTRY PROFILES

    The Largest Markets And Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
    • United States
    • China
    • Japan
    • Germany
    • United Kingdom
    • France
    • Brazil
    • Italy
    • Russian Federation
    • India
    • Canada
    • Australia
    • Republic of Korea
    • Spain
    • Mexico
    • Indonesia
    • Netherlands
    • Turkey
    • Saudi Arabia
    • Switzerland
    • Sweden
    • Nigeria
    • Poland
    • Belgium
    • Argentina
    • Norway
    • Austria
    • Thailand
    • United Arab Emirates
    • Colombia
    • Denmark
    • South Africa
    • Malaysia
    • Israel
    • Singapore
    • Egypt
    • Philippines
    • Finland
    • Chile
    • Ireland
    • Pakistan
    • Greece
    • Portugal
    • Kazakhstan
    • Algeria
    • Czech Republic
    • Qatar
    • Peru
    • Romania
    • Vietnam

  12. LIST OF TABLES

    1. Key Findings In 2024
    2. Market Volume, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
    3. Market Value: Historical Data (2012–2024) and Forecast (2025–2035)
    4. Per Capita Consumption, by Country, 2022–2024
    5. Production, In Physical Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    6. Imports, In Physical Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    7. Imports, In Value Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    8. Import Prices, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    9. Exports, In Physical Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    10. Exports, In Value Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    11. Export Prices, By Country: Historical Data (2012–2024) and Forecast (2025–2035)

  13. LIST OF FIGURES

    1. Market Volume, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
    2. Market Value: Historical Data (2012–2024) and Forecast (2025–2035)
    3. Consumption, by Country, 2024
    4. Market Volume Forecast to 2035
    5. Market Value Forecast to 2035
    6. Market Size and Growth, By Product
    7. Average Per Capita Consumption, By Product
    8. Exports and Growth, By Product
    9. Export Prices and Growth, By Product
    10. Production Volume and Growth
    11. Exports and Growth
    12. Export Prices and Growth
    13. Market Size and Growth
    14. Per Capita Consumption
    15. Imports and Growth
    16. Import Prices
    17. Production, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
    18. Production, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
    19. Production, by Country, 2024
    20. Production, In Physical Terms, by Country: Historical Data (2012–2024) and Forecast (2025–2035)
    21. Imports, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
    22. Imports, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
    23. Imports, In Physical Terms, By Country, 2024
    24. Imports, In Physical Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    25. Imports, In Value Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    26. Import Prices, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    27. Exports, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
    28. Exports, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
    29. Exports, In Physical Terms, By Country, 2024
    30. Exports, In Physical Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    31. Exports, In Value Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    32. Export Prices, By Country: Historical Data (2012–2024) and Forecast (2025–2035)

Recommended posts

Free Data: Antibiotics - World
Table
Antibiotics - World - Table
Dashboard
Antibiotics - World - Dashboard
Report
Antibiotics - World - Report